Overview of advances in cardiovascular disease treatment and prevention: The evolving role of antiplatelet therapy

American Journal of Health-System Pharmacy

Volumn 65, Issue 13 SUPPL. 5, 2008, Pages

  Talbert, Robert L ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aspirin; Cardiovascular diseases; Clopidogrel; Combined therapy; Mortality; Platelet aggregation inhibitors; Protocols; Stents; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; MORPHINE; PACLITAXEL; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CONFERENCE PAPER; DRUG ELUTING STENT; DRUG WITHDRAWAL; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEART CATHETERIZATION; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAINTENANCE THERAPY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; RISK FACTOR; STANDARD; THROMBOSIS; UNITED STATES; UNSTABLE ANGINA PECTORIS;

EID: 46149083256     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080129     Document Type: Conference Paper

References (11)

1. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics 2008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008; 117:e25-e146.
2. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation. 2007; 116:803-77.
3. Smith SC Jr, Feldman TE, Hershfeld JW et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention - Summary Article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. Circulation. 2005; 113:1156-75.
4. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA 2007 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004; 110:e82-e293.
5. ten Berg JM, Thijs Plokker HW, Verheug FWA. Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention. Curr Control Trials Cardiovasc Med. 2001; 2:129-40.
6. Spertus JA, Kettelkamp R, Vance C et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Results from the PREMIER registry. Circulation. 2006; 113:2803-09.
7. Applegate RJ, Sacrinty MT, Kutcher MA et al. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008; 51:607-14.
8. Grines CL, Bonow RO, Casey DE Jr. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Intervention, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007; 115:813-8.
9. Hall P, Nakamura S, Maiello L et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation. 1996; 93:215-22.
10. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293:2126-30.
11. Eisenstein EL, Anstrom KJ, Kong DF et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007; 297:159-68.